Pris­on­er #87850-053 does not get to add drug de­vel­op­er to his list of cred­its

Just days af­ter Retrophin shed its last ties to founder Mar­tin Shkre­li, the biotech is re­port­ing that the lead drug he co-in­vent­ed flopped in a piv­otal tri­al. Fos­met­pan­tote­nate flunked both the pri­ma­ry and key sec­ondary end­points in a place­bo-con­trolled tri­al for a rare dis­ease called pan­tothen­ate ki­nase-as­so­ci­at­ed neu­rode­gen­er­a­tion, or PKAN.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER